Published in J Cardiovasc Electrophysiol on June 01, 2006
Atrial-selective sodium channel blockers: do they exist? J Cardiovasc Pharmacol (2008) 1.18
Atrial-selective sodium channel block for the treatment of atrial fibrillation. Expert Opin Emerg Drugs (2009) 1.12
Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation. J Electrocardiol (2009) 1.04
Mechanisms of termination and prevention of atrial fibrillation by drug therapy. Pharmacol Ther (2011) 0.94
Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation. Nat Rev Cardiol (2016) 0.83
Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update. Vasc Health Risk Manag (2013) 0.78
The inward rectifier current inhibitor PA-6 terminates atrial fibrillation and does not cause ventricular arrhythmias in dedicated goat and dog models. Br J Pharmacol (2017) 0.76
Antiarrhythmic and electrophysiologic effects of flecainide on acutely induced atrial fibrillation in healthy horses. J Vet Intern Med (2014) 0.76
Too little, too late: chasing atrial fibrillation with sodium channel antagonists. J Cardiovasc Electrophysiol (2006) 0.75
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J (2010) 16.39
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace (2010) 6.31
Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res (2002) 4.86
Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice. J Clin Invest (2009) 3.45
Hybrid thoracoscopic surgical and transvenous catheter ablation of atrial fibrillation. J Am Coll Cardiol (2012) 2.80
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J (2016) 2.70
Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol (2010) 2.59
PITX2c is expressed in the adult left atrium, and reducing Pitx2c expression promotes atrial fibrillation inducibility and complex changes in gene expression. Circ Cardiovasc Genet (2011) 2.56
Electropathological substrate of longstanding persistent atrial fibrillation in patients with structural heart disease: epicardial breakthrough. Circulation (2010) 2.56
Electropathological substrate of long-standing persistent atrial fibrillation in patients with structural heart disease: longitudinal dissociation. Circ Arrhythm Electrophysiol (2010) 2.51
Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation. Circulation (2012) 1.81
Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins. Circulation (2011) 1.62
Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients. Eur Heart J (2011) 1.60
Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability. Heart Rhythm (2010) 1.59
Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort. Europace (2011) 1.57
Atrial ultrastructural changes during experimental atrial tachycardia depend on high ventricular rate. J Cardiovasc Electrophysiol (2004) 1.57
The L-type Ca2+-channel subunits alpha1C and beta2 are not downregulated in atrial myocardium of patients with chronic atrial fibrillation. J Mol Cell Cardiol (2003) 1.54
Effects of acute atrial dilation on heterogeneity in conduction in the isolated rabbit heart. J Cardiovasc Electrophysiol (2003) 1.54
Mechanoelectrical coupling enhances initiation and affects perpetuation of atrial fibrillation during acute atrial dilation. Heart Rhythm (2010) 1.54
Patients originally diagnosed with idiopathic atrial fibrillation more often suffer from insidious coronary artery disease compared to healthy sinus rhythm controls. Heart Rhythm (2012) 1.53
Triggering pulmonary veins: a paradoxical predictor for atrial fibrillation recurrence after PV isolation. J Cardiovasc Electrophysiol (2009) 1.52
Changes in P-wave area and P-wave duration after circumferential pulmonary vein isolation. Europace (2010) 1.51
Combined blockade of early and late activated atrial potassium currents suppresses atrial fibrillation in a pig model of obstructive apnea. Heart Rhythm (2011) 1.43
Does flecainide regain its antiarrhythmic activity after electrical cardioversion of persistent atrial fibrillation? Heart Rhythm (2005) 1.42
Automatic mapping of human atrial fibrillation by template matching. Heart Rhythm (2006) 1.42
The right recommendations for the wrong reasons? Europace (2013) 1.39
"John Brown's baby had a cough": a central role for TRPV1? Am J Respir Crit Care Med (2011) 1.39
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace (2016) 1.39
Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension (2012) 1.35
Time course and mechanisms of endo-epicardial electrical dissociation during atrial fibrillation in the goat. Cardiovasc Res (2010) 1.33
Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation. Eur Heart J (2012) 1.30
Adenosine testing after second-generation balloon devices (cryothermal and laser) mediated pulmonary vein ablation for atrial fibrillation. J Interv Card Electrophysiol (2014) 1.29
The role of atrial dilatation in the domestication of atrial fibrillation. Prog Biophys Mol Biol (2003) 1.17
Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy. Am Heart J (2012) 1.17
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace (2013) 1.16
Electrical and contractile remodeling during the first days of atrial fibrillation go hand in hand. Circulation (2003) 1.15
Post-operative atrial fibrillation: a maze of mechanisms. Europace (2011) 1.12
Renal sympathetic denervation provides ventricular rate control but does not prevent atrial electrical remodeling during atrial fibrillation. Hypertension (2012) 1.09
Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation. J Mol Cell Cardiol (2008) 1.09
Alterations of atrial Ca(2+) handling as cause and consequence of atrial fibrillation. Cardiovasc Res (2010) 1.06
Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation. Heart Rhythm (2011) 1.06
Paroxysmal atrial fibrillation: just a matter of nerves? Heart Rhythm (2006) 1.06
Chronic atrial dilation, electrical remodeling, and atrial fibrillation in the goat. J Am Coll Cardiol (2006) 1.06
Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation. Cardiovasc Res (2002) 1.05
Multiple potential molecular contributors to atrial hypocontractility caused by atrial tachycardia remodeling in dogs. Circ Arrhythm Electrophysiol (2010) 1.05
Reverse structural and gap-junctional remodeling after prolonged atrial fibrillation in the goat. Circulation (2003) 1.04
Synthesis and in vitro and in vivo structure-activity relationships of novel antifungal triazoles for dermatology. J Med Chem (2005) 1.04
Effect of renal denervation on neurohumoral activation triggering atrial fibrillation in obstructive sleep apnea. Hypertension (2013) 1.03
Loss of continuity in the thin epicardial layer because of endomysial fibrosis increases the complexity of atrial fibrillatory conduction. Circ Arrhythm Electrophysiol (2013) 1.01
Mechanisms of perpetuation of atrial fibrillation in chronically dilated atria. Prog Biophys Mol Biol (2008) 1.01
The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases-2/-9 in atrial myocytes. Basic Res Cardiol (2009) 1.01
Re-expression of alpha skeletal actin as a marker for dedifferentiation in cardiac pathologies. J Cell Mol Med (2009) 1.01
Transmural conduction is the predominant mechanism of breakthrough during atrial fibrillation: evidence from simultaneous endo-epicardial high-density activation mapping. Circ Arrhythm Electrophysiol (2013) 1.00
Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. Eur Heart J (2009) 1.00
Fibrillatory conduction in the atrial free walls of goats in persistent and permanent atrial fibrillation. Circ Arrhythm Electrophysiol (2010) 0.99
Miconazole induces changes in actin cytoskeleton prior to reactive oxygen species induction in yeast. J Biol Chem (2007) 0.99
Evaluation of epicardial microwave ablation lesions: histology versus electrophysiology. Ann Thorac Surg (2004) 0.97
Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study. Br J Clin Pharmacol (2012) 0.95
Reconstruction of instantaneous phase of unipolar atrial contact electrogram using a concept of sinusoidal recomposition and Hilbert transform. IEEE Trans Biomed Eng (2014) 0.95
Pharmacological evidence for altered src kinase regulation of I (Ca,L) in patients with chronic atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.94
Intra- and interatrial asynchrony in patients with heart failure. Am J Cardiol (2006) 0.94
Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes. J Clin Invest (2014) 0.93
Management of atrial fibrillation in patients with heart failure. Eur Heart J (2007) 0.93
Overexpression of cAMP-response element modulator causes abnormal growth and development of the atrial myocardium resulting in a substrate for sustained atrial fibrillation in mice. Int J Cardiol (2011) 0.93
Prevalence, characteristics, and predictors of pulmonary vein narrowing after isolation using the pulmonary vein ablation catheter. Circ Arrhythm Electrophysiol (2011) 0.93
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. EuroIntervention (2015) 0.92
S-wave predominance of epicardial electrograms during atrial fibrillation in humans: indirect evidence for a role of the thin subepicardial layer. Heart Rhythm (2004) 0.91
Aldosterone promotes atrial fibrillation. Eur Heart J (2011) 0.91
Robot-assisted epicardial ablation of the pulmonary veins: is a completed isolation necessary? Eur Heart J (2005) 0.90
Effects of electrical stimulation of carotid baroreflex and renal denervation on atrial electrophysiology. J Cardiovasc Electrophysiol (2013) 0.90
Gene therapy for repair of cardiac fibrosis: a long way to Tipperary. Circulation (2005) 0.89
Regulation of nerve growth factor in the heart: the role of the calcineurin-NFAT pathway. J Mol Cell Cardiol (2008) 0.88
Effects of intrapericardial sotalol and flecainide on transmural atrial electrophysiology and atrial fibrillation. J Cardiovasc Electrophysiol (2008) 0.88
Dynamic remodeling of intracellular Ca²⁺ signaling during atrial fibrillation. J Mol Cell Cardiol (2013) 0.88
Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference. Thromb Haemost (2011) 0.87
Bachmann's bundle: a key player in the development of atrial fibrillation? Circ Arrhythm Electrophysiol (2013) 0.86
Analysis of altered gene expression during sustained atrial fibrillation in the goat. Cardiovasc Res (2002) 0.86
Troponin I isoform expression in human and experimental atrial fibrillation. Circulation (2004) 0.86
Development of a substrate of atrial fibrillation during chronic atrioventricular block in the goat. Circulation (2005) 0.86
Stability of complex fractionated atrial electrograms: a systematic review. J Cardiovasc Electrophysiol (2012) 0.85
Four types of complications in paroxysmal atrial fibrillation ablation. Europace (2010) 0.84
Renal denervation: effects on atrial electrophysiology and arrhythmias. Clin Res Cardiol (2014) 0.84
Fractionation of electrograms and linking of activation during pharmacologic cardioversion of persistent atrial fibrillation in the goat. J Cardiovasc Electrophysiol (2004) 0.83
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg (2016) 0.82